IMMUNE PHARMACEUTICALS INC — Form D

IMMUNE PHARMACEUTICALS INC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-14. The offering totals $11.7M, of which $11.7M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2014-04-14
• Form: D
• Accession: 0001208261-14-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $11.7M
• Amount sold: $11.7M
• Investors: 42
• Date of first sale: 2014-03-14
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-215479

Issuer

• Name: IMMUNE PHARMACEUTICALS INC
• CIK: 0001208261
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 708 THIRD AVENUE, NEW YORK, NY, 10017
• Phone: 914-606-3500

Officers, directors & promoters (7)

More

• CIK 1208261 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search